Investigating Vortex Ring Propagation Speed Past Prosthetic Heart Valves: Implications for Assessing Valve Performance

Author(s):  
Ann Bailey ◽  
Michelle Beatty ◽  
Olga Pierrakos
Author(s):  
Jennifer Bartell ◽  
Olga Pierrakos ◽  
Lawrence Scotten

The study of heart valve performance (healthy, diseased, and prosthetic) has traditionally involved the examination of transvalvular characteristics, such as pressure gradients and effective and geometric orifice areas. However, recent research has shown that a key downstream flow characteristic, vortex ring formation, should not be overlooked because quantifying this mechanism provides insight into the assessment of valve performance [1]. Vortex ring formation, which is dependent on the valve design [1], is the roll-up of the shear layers shedding past valve leaflets. Governed by a universal time-scale or formation number (FN) that is based on the jet length to diameter ratio (L/D), vortex ring formation provides insight into the kinematics of optimizing effective fluid transport. It has been shown that growth of the leading vortex ring ceases at a FN between 3.5 and 4.5 in various biological systems [2], but most of these studies have assumed a constant or fixed orifice opening. However, incorporating a time-varying jet diameter rather than the constant valve annulus diameter has recently been identified by Dabiri and Gharib as a key factor in the characterization of vortex ring formation and provides a more complete picture of impulse generation and efficiency in vortical flows [2]. This dynamic formation number is governed by the following equation: (L/D)*=∫0tU¯/D¯dt(1) where U is velocity, D is diameter, t is time, and the overbar indicates a time average. Estimating (L/D)* can serve as a powerful evaluation tool in comparison to conventional methods of FN calculation that use either an averaged diameter or the valve annulus diameter. Ideally suited for unsteady flows, such as the opening phase and leaflet motions in heart valves, (L/D)* can provide insight into assessing the performance of natural and prosthetic heart valves (PHVs).


1973 ◽  
Vol 29 (03) ◽  
pp. 694-700 ◽  
Author(s):  
Paul L. Rifkin ◽  
Marjorie B. Zucker

SummaryDipyridamole (Persantin) is reported to prolong platelet survival and inhibit embolism in patients with prosthetic heart valves, but its mechanism of action is unknown. Fifty jxM dipyridamole failed to reduce the high percentage of platelets retained when heparinized human blood was passed through a glass bead column, but prolonged the inhibition of retention caused by disturbing blood in vitro. Possibly the prostheses act like disturbance. Although RA 233 was as effective as dipyridamole in inhibiting the return of retention, it was less effective in preventing the uptake of adenosine into erythrocytes, and more active in inhibiting ADP-induced aggregation and release. Thus there is no simple relation between these drug effects.


Circulation ◽  
1968 ◽  
Vol 37 (4s2) ◽  
Author(s):  
ROBERT A. INDEGLIA ◽  
MICHAEL A. SHEA ◽  
RICHARD L. VARCO ◽  
EUGENE F. BERNSTEIN

Circulation ◽  
1973 ◽  
Vol 48 (1s3) ◽  
Author(s):  
MICHAEL L. SCHWARTZ ◽  
DEAN SHELDON ◽  
FRANK DORMAN ◽  
PERRY L. BLACKSHEAR ◽  
RICHARD L. VARCO ◽  
...  

2019 ◽  
Vol 25 ◽  
pp. 100421
Author(s):  
Noel Alberto Flórez ◽  
German Camilo Giraldo ◽  
Julian David Yara ◽  
Stephania Galindo-Coral ◽  
Juan David López ◽  
...  

BMJ ◽  
1981 ◽  
Vol 283 (6291) ◽  
pp. 581-582 ◽  
Author(s):  
F Toolis ◽  
R H Robson ◽  
J A Critchley

Sign in / Sign up

Export Citation Format

Share Document